These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 4103275)

  • 1. Effects of lignocaine and propranolol on experimental cardiac arrhythmias.
    Allen JD; Shanks RG; Zaidi SA
    Br J Pharmacol; 1971 May; 42(1):1-12. PubMed ID: 4103275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of Kö 1173, a new anticonvulsant agent on experimental cardiac arrhythmias.
    Allen JD; Ekue JM; Shanks RG; Zaidi SA
    Br J Pharmacol; 1972 Aug; 45(4):561-73. PubMed ID: 5085230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tiprenolol, practolol and propranolol on experimental ventricular tachyarrhythmias.
    Allen JD; Shanks RG
    Br J Pharmacol; 1974 Jun; 51(2):179-85. PubMed ID: 4155971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the experimental anti-arrhythmic properties of acebutolol (M and B 17,803), propranolol and practolol.
    Basil B; Jordan R; Loveless AH; Maxwell DR
    Br J Pharmacol; 1974 Mar; 50(3):323-33. PubMed ID: 4850183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of alinidine on experimental cardiac arrhythmias.
    Harron DW; Allen JD; Wilson R; Shanks RG
    J Cardiovasc Pharmacol; 1982; 4(2):221-5. PubMed ID: 6175804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of antiarrhythmic drugs (verapamil, propranolol and lignocaine) on the electrocardiogram and haematology in adrenaline-induced arrhythmias in dogs anaesthetized with halothane.
    Kitaa JM; Mitema ES
    Br Vet J; 1994; 150(4):365-76. PubMed ID: 8076170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the myocardial-selective alpha 1-adrenoceptor antagonist UK-52046 and atenolol, alone and in combination, on experimental cardiac arrhythmias in dogs.
    Uprichard AG; Harron DW; Wilson R; Shanks RG
    Br J Pharmacol; 1988 Dec; 95(4):1241-54. PubMed ID: 2905912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MS-551 and KCB-328, two class III drugs aggravated adrenaline-induced arrhythmias.
    Xue Y; Yamada C; Aye NN; Hashimoto K
    Br J Pharmacol; 1998 Aug; 124(8):1712-8. PubMed ID: 9756388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the effects of bretylium, lignocaine and propranolol on experimental cardiac arrhythmias.
    Allen JD; Shanks RG; Zaidi SA
    Br J Pharmacol; 1969 Oct; 37(2):526P-527P. PubMed ID: 5348446
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of adrenaline, lignocaine-adrenaline and isoprenaline as a test dose in halothane-anaesthetized lambs.
    Desparmet JF; Berde CB; Schwartz DC; Lunn RJ; Hershenson MB
    Eur J Anaesthesiol; 1991 Mar; 8(2):123-8. PubMed ID: 1908378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiarrhythmic properties of 5-(3-tert-butylamino-2-hydroxy)propoxy-3,4-dihydrocarbostyril hydrochloride (OPC-1085), a newly synthesized, potent beta-adrenoreceptor antagonist.
    Yabuuchi Y; Hashimoto K; Yamashita S; Uno T; Shintani S; Nakagiri N
    Clin Exp Pharmacol Physiol; 1977; 4(6):545-59. PubMed ID: 22416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiarrhythmic and cardiovascular effects of MP 115.
    Allen JD; Deering AH; Kelly JG; Shanks RG
    J Cardiovasc Pharmacol; 1983; 5(6):937-44. PubMed ID: 6196565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental anti-arrhythmic effects of a new beta-adrenergic receptor blocking agent, dl-l-(tert. butylamino)-3-[(2-propinyloxy)phenoxy]2-propanol hydrochloride (dl Kö 1400-Cl)].
    Matsubara I; Hashimoto K; Katano Y; Tsukada T; Matsuda H
    Nihon Yakurigaku Zasshi; 1976 Jul; 72(5):557-71. PubMed ID: 11153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of bretylium on experimental cardiac dysrhythmias.
    Allen JD; Zaidi SA; Shanks RG; Pantridge JF
    Am J Cardiol; 1972 May; 29(5):641-9. PubMed ID: 5021494
    [No Abstract]   [Full Text] [Related]  

  • 15. The reversal of experimental cardiac arrhythmias by indoramin (Wy 21901).
    Alps BJ; Hill M; Fidler K; Johnson ES; Wilson AB
    J Pharm Pharmacol; 1971 Sep; 23(9):678-86. PubMed ID: 4398246
    [No Abstract]   [Full Text] [Related]  

  • 16. The acute antiarrhythmic effects of droxicainide and lidocaine in unanesthetized dogs.
    Aberg G; Ronfeld R; Smith E
    J Cardiovasc Pharmacol; 1984; 6(2):355-60. PubMed ID: 6200728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 8-(3-diethylaminopropyl)-6,6-dimethyl-(2-phenyl-1 H-imidazo(4,5 h))isoquinoline-7,9-(6H)-dione dihydrochloride (AR-LH31) on experimental cardiac arrhythmias in dogs.
    Kerr MJ; Harron DW; Wilson R; Shanks RG
    Arzneimittelforschung; 1985; 35(1A):197-200. PubMed ID: 3838674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-arrhythmic effect of nadolol in experimental arrhythmias: comparison with propranolol and alprenolol.
    Nakashima M; Takiguchi Y; Oguro K; Sogabe K; Hashimoto H
    J Pharmacobiodyn; 1985 Jan; 8(1):1-10. PubMed ID: 4009395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between effectiveness of intramuscular and intravenous lignocaine on ventricular arrhythmia complicating acute myocardial infarction.
    Rydén L; Waldenström A; Ehn L; Holmberg S; Husaini M
    Br Heart J; 1973 Nov; 35(11):1124-31. PubMed ID: 4128310
    [No Abstract]   [Full Text] [Related]  

  • 20. Re-entrant ventricular arrhythmias in the late myocardial infarction period. 4. Mechanism of action of lidocaine.
    El-Sherif N; Scherlag BJ; Lazzara R; Hope RR
    Circulation; 1977 Sep; 56(3):395-402. PubMed ID: 69503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.